 At week 6 of treatment the investigator will evaluate the treated area for all patients. If the investigator determines that there is no change in the disease spread area or lesion number compared to Day 1, study therapy is to be discontinued prior to 14 weeks 98 days of treatment and the patient will be considered as not cleared. Last observation carried forward LOCF method will be used to analyze such patients. 